Individuals with mental illness in America continue to face socioeconomic barriers when it comes to accessing necessary care ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

Medically reviewed by Paria Sanaty Zadeh, PharmD Key Takeaways Melatonin and magnesium supplements are combined to improve ...

In adolescents, reporting higher than person-level mean social media use in years 1 and 2 was associated with greater depressive symptoms.

While there is no cure for the common cold, a variety of over-the-counter treatments and home remedies may help relieve your ...

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

Patients with BS are associated with disrupted sleep quality that appears to be driven by active disease status and comorbid fibromyalgia.

As WVU Medicine has grown from seven hospitals to 25 in the last six years, Todd Karpinski, PharmD, vice president and chief pharmacy officer, said the health system has found itself confronting the ...

Michael McGuire, PharmD, reviewed Mental Health America’s recent publication on the current state of mental health in America and addressed socioeconomic barriers in access to care.

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at ...

Amanda Matter, PharmD (c), is a final-year pharmacy student at MCPHS University and works at Boston Medical Center. Her interests include diagnostic policy, managed care strategy, and the evolving ...

Loopback Analytics is excited to welcome Elizabeth Cherry, PharmD, MMHC, CSP, as Vice President of Access Solutions. A ...